Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Lung Diseases, Interstitial
Description
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features. MeSH
Hierarchy View
Subtype Terms (8)
Alveolitis, Extrinsic Allergic
11 drugs (9 approved, 2 experimental)
Anti-Glomerular Basement Membrane Disease
2 drugs (1 approved, 1 experimental)
Granulomatosis with Polyangiitis
33 drugs (28 approved, 5 experimental)
Histiocytosis, Langerhans-Cell
58 drugs (43 approved, 15 experimental)
Pneumoconiosis
3 drugs (1 approved, 2 experimental)
Pulmonary Fibrosis
52 drugs (31 approved, 21 experimental)
Radiation Pneumonitis
21 drugs (13 approved, 8 experimental)
Sarcoidosis, Pulmonary
33 drugs (24 approved, 9 experimental)
Phase 2 Indicated Drugs (30)
Phase 1 Indicated Drugs (6)
Other Experimental Indicated Drugs (7)
Organization Involved with Phase 4 Indications (23)
Organization Involved with Phase 3 Indications (40)
National Center for Research Resources (NCRR)
National Institutes of Health (NIH)
Postgraduate Institute of Medical Education and Research
Sanjay Gandhi Postgraduate Institute of Medical Sciences
St. Antonius Hospital, Nieuwegein
Organization Involved with Phase 2 Indications (38)
A.O. Ospedale Papa Giovanni XXIII
Azienda Ospedaliera Istituti Ospitalieri Cremona
Belarusian State Medical University
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (5)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
